Dimethyl fumarate-associated lymphopenia: Risk factors and clinical significance
{{output}}
Background: Dimethyl fumarate (DMF), a disease-modifying therapy for multiple sclerosis (MS), causes lymphopenia in a fraction of patients. The clinical significance of this is unknown. Several cases of progressive multifocal leu... ...
